Dr. Laura Seeholzer did her PhD at Rockefeller University with Dr. Vanessa Ruta and post-doctoral studies at UCSF with Dr. David Julius.

Dr. Feng Vankee Lin is a leader in research on brain aging and dementia. Dr. Lin's career has been devoted to understanding the neural mechanisms involved in brain aging and brain plasticity, with a special focus on early detection and prevention of Alzheimer’s disease (AD). Her research approach integrates principles and findings from cognitive theory, clinical neuroscience, and computational neuroscience. This approach is complemented by Dr.

Dr. Susan Clark is an astrophysicist, with primary research interests in cosmic magnetism and the physics of the interstellar medium. She is interested in interdisciplinary collaborations that spark new approaches to using heterogeneous data for physical discovery.

Dr. Clark's group is working on a diverse set of problems involving Galactic and extragalactic magnetism, 3D ISM structure, interstellar turbulence, star formation, and polarized cosmological foregrounds, among other topics.

Dr. Bomi Lee's lab is dedicated to unraveling the complexities of the immune microenvironment and its role in the pathogenesis of pancreatic diseases, such as pancreatitis and pancreatic cancer. By leveraging cutting-edge technology, innovative experimental and genetic animal models, as well as human specimens from donors, we aim to identify novel immune markers and potential therapeutic targets. Our goal is to advance the understanding of immune cells and their contributions to these diseases and to translate our findings into innovative treatments.

Dr. Fernando Alarid-Escudero is an Assistant Professor of Health Policy at Stanford University School of Medicine. He obtained his Ph.D. in Health Decision Sciences from the University of Minnesota School of Public Health. His research focuses on developing statistical and decision-analytic models to identify optimal prevention, control, and treatment policies and conducting cost-effectiveness analyses to address a wide range of public health problems. He has also developed novel methods to quantify the value of future research. Dr.

Dr. Marc Lipsitch started his appointments at Stanford on January 1, 2026. From 1999-2025 he was a faculty member at Harvard TH Chan School of Public Health, where he was Professor of Epidemiology (2006-2025) and founding Director of the Center for Communicable Disease Dynamics (2009-2025).

Dr. Christoph A. Thaiss is an Assistant Professor of Pathology at Stanford University. His lab studies how interactions between environment, body, and brain impact physiology and disease over the lifespan. Christoph received his undergraduate training from the University of Bonn, Yale University, ETH Zurich, and the Broad Institute of MIT and Harvard. Following his Ph.D. studies at the Weizmann Institute of Science, he joined the faculty at the University of Pennsylvania.

Dr. Stephen Hinshaw is an Assistant Professor in the Department of Molecular and Cellular Physiology and the Faculty co-Director of the Stanford Cryo-Electron Microscopy Center (cEMc). His laboratory develops and applies cutting-edge tools in chemical and structural biology to uncover fundamental cellular mechanisms and translate these insights into powerful new pharmacological strategies.

The mission of Dr. Timothy Durazzo's BRASS lab is to better understand how the interplay between biomedical, psychological and social factors influence treatment outcome in Veterans and civilians seeking treatment for alcohol and substance use disorders. To accomplish this mission, the multidisciplinary team integrates information from advanced neuroimaging, neurocognitive assessment, psychodiagnostic and genotyping methods to identify the biopsychosocial factors associated with relapse and sustained sobriety.